Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $246,473 - $279,452
5,137 New
5,137 $278,000
Q2 2023

Jul 07, 2023

SELL
$63.71 - $70.74 $13,761 - $15,279
-216 Reduced 6.34%
3,192 $204,000
Q1 2023

Apr 12, 2023

SELL
$65.71 - $74.53 $13,076 - $14,831
-199 Reduced 5.52%
3,408 $236,000
Q4 2022

Jan 05, 2023

SELL
$68.48 - $81.09 $16,572 - $19,623
-242 Reduced 6.29%
3,607 $259,000
Q3 2022

Oct 06, 2022

SELL
$0.13 - $76.84 $5 - $2,996
-39 Reduced 1.0%
3,849 $273,000
Q2 2022

Jul 13, 2022

SELL
$72.62 - $79.98 $4,357 - $4,798
-60 Reduced 1.52%
3,888 $299,000
Q1 2022

Apr 06, 2022

SELL
$61.48 - $73.72 $27,666 - $33,174
-450 Reduced 10.23%
3,948 $288,000
Q4 2021

Jan 10, 2022

BUY
$53.63 - $62.52 $7,400 - $8,627
138 Added 3.24%
4,398 $275,000
Q2 2021

Jul 02, 2021

SELL
$61.91 - $67.42 $124,439 - $135,514
-2,010 Reduced 32.06%
4,260 $285,000
Q4 2020

Jan 06, 2021

SELL
$57.74 - $65.43 $17,322 - $19,629
-300 Reduced 4.57%
6,270 $389,000
Q3 2020

Oct 08, 2020

BUY
$57.43 - $63.64 $28,427 - $31,501
495 Added 8.15%
6,570 $396,000
Q2 2020

Jul 08, 2020

SELL
$54.82 - $64.09 $8,223 - $9,613
-150 Reduced 2.41%
6,075 $357,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $6,151 - $8,023
125 Added 2.05%
6,225 $399,000
Q2 2019

Jul 08, 2019

SELL
$44.62 - $49.34 $35,696 - $39,472
-800 Reduced 11.59%
6,100 $277,000
Q4 2018

Jan 03, 2019

SELL
$48.76 - $63.23 $6,728 - $8,725
-138 Reduced 1.96%
6,900 $358,000
Q3 2018

Oct 09, 2018

SELL
$55.19 - $62.25 $2,759 - $3,112
-50 Reduced 0.71%
7,038 $437,000
Q2 2018

Jul 13, 2018

SELL
$50.53 - $62.98 $15,159 - $18,894
-300 Reduced 4.06%
7,088 $393,000
Q1 2018

Apr 04, 2018

SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 1.34%
7,388 $468,000
Q4 2017

Jan 08, 2018

SELL
$59.94 - $65.35 $77,922 - $84,954
-1,300 Reduced 14.79%
7,488 $459,000
Q3 2017

Oct 05, 2017

BUY
$55.23 - $63.74 $485,361 - $560,147
8,788
8,788 $561,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First National Bank Of Mount Dora, Trust Investment Services Portfolio

Follow First National Bank Of Mount Dora, Trust Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Mount Dora, Trust Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Mount Dora, Trust Investment Services with notifications on news.